Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | LAP3 | P28838 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL609942 | 0.98 | GRIK1 (0.49) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL10985746 | 0.98 | GRIK1 (0.49) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL5490300 | 0.98 | GRIK1 (0.49) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL5495673 | 0.98 | GRIK1 (0.49) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL3676331 | 0.98 | GRIK1 (0.49) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL11598110 | 0.98 | GRIK1 (0.46) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL325396 | 0.98 | GRIK1 (0.49) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL66570 | 0.98 | GRIK1 (0.49) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL133143 | 0.98 | GRIK1 (0.49) | GRIK1GRIK2SLC1A2SLC1A1GPR84 | |
| SCHEMBL5494791 | 0.98 | GRIK1 (0.49) | GRIK1GRIK2SLC1A2SLC1A1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388962-A1 | RNA MAPPING METHODS WITH HIGH SEQUENCE COVERAGE | WATERS TECHNOLOGIES CORP (US) | 2025-12-25 | — | — | US | claimed |
| WO-2025235739-A1 | RNA MAPPING METHODS WITH HIGH SEQUENCE COVERAGE | WATERS TECHNOLOGIES CORPORATION (US) | 2025-11-13 | — | — | WO | claimed |
| CN-115707966-B | Purification method of fluorescein-labeled nucleoside triphosphate | 广州达安基因股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-119530213-A | Method for purifying circular RNA based on SDVB reverse phase column | 星锐医药(苏州)有限公司 | 2025-02-28 | — | — | CN | claimed |
| WO-2023019670-A1 | PURIFICATION METHOD FOR FLUORESCEIN-LABELED NUCLEOSIDE TRIPHOSPHATE | 广州达安基因股份有限公司 | 2023-02-23 | — | — | WO | claimed |
| CN-115707966-A | Method for purifying fluorescein labeled nucleoside triphosphate | 广州达安基因股份有限公司 | 2023-02-21 | — | — | CN | claimed |
| CN-110272463-A | A kind of chromatographic process of novel separation oligonucleotides | 苏州博熠信生物科技有限公司 | 2019-09-24 | — | — | CN | claimed |
| US-6361940-B1 | IMMOBILIZATION; GENETIC ENGINEERING | QIAGEN GENOMICS, INC. | 2002-03-26 | — | — | US | claimed |
| US-12509483-B2 | Method for producing nucleic acid oligomers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-12-30 | — | — | US | disclosed |
| US-20250388962-A1 | RNA MAPPING METHODS WITH HIGH SEQUENCE COVERAGE | WATERS TECHNOLOGIES CORP (US) | 2025-12-25 | — | — | US | disclosed |
| WO-2025235739-A1 | RNA MAPPING METHODS WITH HIGH SEQUENCE COVERAGE | WATERS TECHNOLOGIES CORPORATION (US) | 2025-11-13 | — | — | WO | disclosed |
| US-12391716-B2 | Process of preparing nucleic acid oligomer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-08-19 | — | — | US | disclosed |
| CN-115707966-B | Purification method of fluorescein-labeled nucleoside triphosphate | 广州达安基因股份有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-115707966-B | Purification method of fluorescein-labeled nucleoside triphosphate | 广州达安基因股份有限公司 | 2025-06-13 | — | — | CN | disclosed |
| EP-0488204-A2 | Room Temperature-curable organopolysiloxane composition | Dow Corning Toray Silicone Company, Limited (JP) | 1992-06-03 | — | — | EP | disclosed |
| EP-0483776-A2 | Room temperature-curable organopolysiloxane composition | Dow Corning Toray Silicone Company, Limited (JP) | 1992-05-06 | — | — | EP | disclosed |
| EP-0050453-B1 | AN OIL-RESISTANT GASKET MATERIAL AND PACKING MATERIAL | Toray Silicone Company Limited (JP) | 1985-04-24 | — | — | EP | disclosed |
| EP-0050453-A1 | An oil-resistant gasket material and packing material | Toray Silicone Company Limited (JP) | 1982-04-28 | — | — | EP | disclosed |
| US-4156674-A | PLATINUM OR COMPOUND THEREOF, CARBON BLACK AND A TRIAZOLE FOR SELF-EXTINGUISHING CHARACTER, CURING CATALYST AND A SILICON CONTAINING CROSSLINKER | TORAY SILICONE COMPANY, LTD. (JP) | 1979-05-29 | — | — | US | disclosed |
| US-3997496-A | Process for the preparation of fluorosilicone polymers and copolymers | GENERAL ELECTRIC COMPANY (US) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12391716-B2 | Process of preparing nucleic acid oligomer | POLRMT, RNGTT, POLM | GRIK1 4656/4885GRIK2 4718/4885SLC1A2 4805/4885 |
| US-12509483-B2 | Method for producing nucleic acid oligomers | POLM, RNGTT, POLRMT | GRIK1 3178/4885GRIK2 3012/4885SLC1A2 3558/4885 |
| US-20250388962-A1 | RNA MAPPING METHODS WITH HIGH SEQUENCE COVERAGE | RNGTT, METTL16, RNASEL | GRIK1 4841/4885GRIK2 4835/4885SLC1A2 4125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.